Annual Current Liabilities
$14.69 M
-$29.00 K-0.20%
December 31, 2023
Summary
- As of February 8, 2025, INZY annual total current liabilities is $14.69 million, with the most recent change of -$29.00 thousand (-0.20%) on December 31, 2023.
- During the last 3 years, INZY annual current liabilities has risen by +$4.71 million (+47.26%).
- INZY annual current liabilities is now -0.20% below its all-time high of $14.71 million, reached on December 31, 2022.
Performance
INZY Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$18.34 M
+$2.80 M+18.04%
September 30, 2024
Summary
- As of February 8, 2025, INZY quarterly total current liabilities is $18.34 million, with the most recent change of +$2.80 million (+18.04%) on September 30, 2024.
- Over the past year, INZY quarterly current liabilities has increased by +$2.80 million (+18.04%).
- INZY quarterly current liabilities is now at all-time high.
Performance
INZY Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
INZY Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.2% | +18.0% |
| 3 y3 years | +47.3% | +24.7% |
| 5 y5 years | +514.7% | +24.7% |
INZY Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.2% | +26.2% | at high | +73.5% |
| 5 y | 5-year | -0.2% | +353.8% | at high | +466.9% |
| alltime | all time | -0.2% | +514.7% | at high | +466.9% |
Inozyme Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.34 M(+18.0%) |
| Jun 2024 | - | $15.54 M(+25.3%) |
| Mar 2024 | - | $12.41 M(-15.5%) |
| Dec 2023 | $14.69 M(-0.2%) | $14.69 M(+19.6%) |
| Sep 2023 | - | $12.28 M(+1.6%) |
| Jun 2023 | - | $12.08 M(-4.0%) |
| Mar 2023 | - | $12.58 M(-14.5%) |
| Dec 2022 | $14.71 M | $14.71 M(+12.0%) |
| Sep 2022 | - | $13.13 M(+24.2%) |
| Jun 2022 | - | $10.57 M(-13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $12.26 M(+5.4%) |
| Dec 2021 | $11.63 M(+16.6%) | $11.63 M(+30.1%) |
| Sep 2021 | - | $8.94 M(+28.3%) |
| Jun 2021 | - | $6.97 M(+2.0%) |
| Mar 2021 | - | $6.83 M(-31.5%) |
| Dec 2020 | $9.97 M(+208.2%) | $9.97 M(+1.6%) |
| Sep 2020 | - | $9.81 M(+45.9%) |
| Jun 2020 | - | $6.73 M(+37.0%) |
| Mar 2020 | - | $4.91 M(+51.7%) |
| Dec 2019 | $3.24 M(+35.5%) | $3.24 M |
| Dec 2018 | $2.39 M | - |
FAQ
- What is Inozyme Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Inozyme Pharma?
- What is Inozyme Pharma annual current liabilities year-on-year change?
- What is Inozyme Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Inozyme Pharma?
- What is Inozyme Pharma quarterly current liabilities year-on-year change?
What is Inozyme Pharma annual total current liabilities?
The current annual current liabilities of INZY is $14.69 M
What is the all time high annual current liabilities for Inozyme Pharma?
Inozyme Pharma all-time high annual total current liabilities is $14.71 M
What is Inozyme Pharma annual current liabilities year-on-year change?
Over the past year, INZY annual total current liabilities has changed by -$29.00 K (-0.20%)
What is Inozyme Pharma quarterly total current liabilities?
The current quarterly current liabilities of INZY is $18.34 M
What is the all time high quarterly current liabilities for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total current liabilities is $18.34 M
What is Inozyme Pharma quarterly current liabilities year-on-year change?
Over the past year, INZY quarterly total current liabilities has changed by +$2.80 M (+18.04%)